AEHR affiliate plans sale of 1,717 common shares

An affiliate of AEHR filed a notice of proposed sale of restricted shares.

Rhea-AI Filing Summary

An affiliate of AEHR filed a notice of proposed sale of restricted shares. The filing lists 1,717 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $228,361.17 and a proposed sale date of 08/12/2026.

The securities to be sold originated from restricted stock vesting awards treated as compensation, including 1,159 shares vesting on 07/11/2025 and 558 shares vesting on 07/27/2025.

Key Figures

Shares proposed for sale: 1,717 shares Aggregate market value: $228,361.17 Proposed sale date: 08/12/2026 +2 more

5 metrics

Shares proposed for sale 1,717 shares Common stock listed in the Form 144 securities information section

Aggregate market value $228,361.17 Value associated with the 1,717 shares proposed for sale

Proposed sale date 08/12/2026 Date associated with the planned NASDAQ sale of common shares

Restricted stock vesting 1 1,159 shares Shares vesting on 07/11/2025 as compensation

Restricted stock vesting 2 558 shares Shares vesting on 07/27/2025 as compensation

Key Terms

Form 144, Restricted Stock Vesting, Compensation, Securities To Be Sold

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 07/11/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"1159 | 07/11/2025 | Compensation Common | 07/27/2025"

Securities To Be Sold regulatory

"NASDAQ 144: Securities To Be Sold Common | 07/11/2025"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AEHR’s latest Form 144 filing disclose?

The Form 144 filing discloses a planned sale of 1,717 shares of AEHR common stock with an aggregate market value of $228,361.17, originating from vested restricted stock awards treated as compensation.

How many AEHR shares are proposed to be sold under this Form 144?

The filing lists a proposed sale of 1,717 shares of AEHR common stock. These shares are associated with previously vested restricted stock awards and are expected to be sold through Fidelity Brokerage Services LLC on NASDAQ.

What is the proposed sale date and value for AEHR shares in this Form 144?

The proposed sale date is 08/12/2026, with an aggregate market value of $228,361.17 for the 1,717 shares of AEHR common stock listed. The filing identifies NASDAQ as the trading market.

How were the AEHR shares in the Form 144 acquired?

The shares were acquired through restricted stock vesting as compensation, including 1,159 shares vesting on 07/11/2025 and 558 shares vesting on 07/27/2025, according to the filing’s securities-to-be-sold section.

Which broker and exchange are involved in the AEHR Form 144 planned sale?

The filing lists Fidelity Brokerage Services LLC as the broker for the proposed sale of 1,717 AEHR common shares, with trading to occur on the NASDAQ market as of the proposed date 08/12/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 03:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783244
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	OLIPHANT LAURA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1717	228361.17	32620450	08/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/11/2025	Restricted Stock Vesting	Issuer			1159	07/11/2025	Compensation
Common	07/27/2025	Restricted Stock Vesting	Issuer			558	07/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Laura Oliphant
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)